Uterine Atony

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2013-02-15
Clinical Trial Update: ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery [Phase 4]
Clinical trial update reporting ED90 dose determination of carbetocin for prevention of uterine atony in women undergoing elective cesarean …
FDA approval · 2013-01-31
FDA Approved: METHYLERGONOVINE MALEATE — Supplemental Application (Pharmacist Pharmaceutical, LLC)
FDA approved a supplemental application for METHYLERGONOVINE MALEATE from Pharmacist Pharmaceutical, LLC. This action approves the supplemen…
CLINICAL_TRIALS trial_result · 2012-11-15
Clinical Trial Update: Uterotonic Efficacy of Oxytocin 2.5 Versus 10 Units During Caesarean Section at Mulago Hospital [NA]
A completed trial comparing oxytocin dosing (2.5 units vs 10 units) during cesarean section to evaluate uterotonic efficacy and effects on u…
CLINICAL_TRIALS withdrawal · 2012-01-11
Clinical Trial Update: Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery? [Phase 4]
A Phase 4 trial evaluating intramyometrial oxytocin during elective cesarean delivery has been withdrawn. The study was associated with post…
CLINICAL_TRIALS trial_result · 2011-11-02
Clinical Trial Update: Up-Down Oxytocin Infusion [Phase 4]
A Phase 4 trial evaluating an up-down oxytocin infusion for uterine atony has completed.
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
FDA approval · 2011-05-02
FDA Approved: METHERGINE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' original ANDA for Methergine (methylergonovine maleate), a generic drug indicated for preventing and tre…
FDA approval · 2010-09-13
FDA Approved: METHYLERGONOVINE MALEATE — Original Application (Pharmacist Pharmaceutical, LLC)
FDA approved an Original Application for methylergonovine maleate (generic) by Pharmacist Pharmaceutical, LLC, making this uterotonic availa…
FDA approval · 2008-11-24
FDA Approved: METHYLERGONOVINE MALEATE — Original Application (American Regent, Inc.)
FDA approval of the generic methylergonovine maleate (ANDA) for obstetric use.